Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

Mostrar otras versiones (2)
Detalles Bibliográficos
Autores principales: Wiedmeier-Nutor, Julia Erin, Iqbal, Madiha, Muñoz, Javier, Bezerra, Evandro D., Garcia Robledo, Juan Esteban, Bansal, Radhika, Johnston, Patrick B, Hathcock, Matthew, Larsen, Jeremy T, Bergsagel, P Leif, Wang, Yucai, Reeder, Craig, Leis, Jose F., Fonseca, Rafael, Palmer, Jeanne, Warsame, Rahma, Kourelis, Taxiarchis, Hayman, Suzanne R, Dingli, David, Kapoor, Prashant, Villasboas, Jose C, Paludo, Jonas, Bennani, Nora N, Ansell, Stephen, Castro, Januario E., Kharfan-Dabaja, Mohamed A., Lin, Yi, Vergidis, Paschalis, Murthy, Hemant, Rosenthal, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:
Poster Session - Car-T - Clinical - Regulatory, Efficacy, Persistence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930047/
http://dx.doi.org/10.1016/S2666-6367(22)00400-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930047/
http://dx.doi.org/10.1016/S2666-6367(22)00400-6

Ejemplares similares